These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 5491454)

  • 21. The strategy for prevention of measles and rubella prevalence with measles-rubella (MR) vaccine in Japan.
    Ihara T
    Vaccine; 2009 May; 27(24):3234-6. PubMed ID: 19366578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA
    Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract]   [Full Text] [Related]  

  • 24. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps.
    Rose VL
    Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963
    [No Abstract]   [Full Text] [Related]  

  • 25. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(7):175-8. PubMed ID: 15729220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM; Flowers CA; Congdon CL
    Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rubella tarantella.
    Marcuse EK
    JAMA; 1970 Dec; 214(11):2061. PubMed ID: 5536487
    [No Abstract]   [Full Text] [Related]  

  • 28. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The national measles and rubella campaign--one year on.
    Commun Dis Rep CDR Wkly; 1995 Nov; 5(45):237. PubMed ID: 8541943
    [No Abstract]   [Full Text] [Related]  

  • 30. The measles/rubella immunisation campaign in Scotland.
    Skinner R; Christie P; Cowden JM
    Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consensus conference on measles.
    Can Commun Dis Rep; 1993 May; 19(10):72-9. PubMed ID: 8348101
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
    Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
    J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against virus disease.
    Krugman S
    Maandschr Kindergeneeskd; 1968 Nov; 36(7):198-206. PubMed ID: 5715991
    [No Abstract]   [Full Text] [Related]  

  • 34. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catch-up immunization programs will eliminate measles threat for most schoolchildren.
    Rafuse J
    CMAJ; 1996 May; 154(10):1567-8. PubMed ID: 8625011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles must go and with it rubella.
    Banatvala JE
    Br Med J (Clin Res Ed); 1987 Jul; 295(6589):2-3. PubMed ID: 3113598
    [No Abstract]   [Full Text] [Related]  

  • 37. Measles, mumps, and rubella: prevention.
    Booy R; Sengupta N; Bedford H; Elliman D
    Clin Evid; 2006 Jun; (15):448-68. PubMed ID: 16973018
    [No Abstract]   [Full Text] [Related]  

  • 38. The Measles Control Campaign and immunisation adverse events.
    Burgess MA; Heath TC; McIntyre PB
    Commun Dis Intell; 1998 Jul; 22(7):136-8. PubMed ID: 9684532
    [No Abstract]   [Full Text] [Related]  

  • 39. Need for measles revaccination.
    John TJ
    Indian Pediatr; 1998 Aug; 35(8):789-91. PubMed ID: 10216577
    [No Abstract]   [Full Text] [Related]  

  • 40. Measles and rubella in the World Health Organization European region: diversity creates challenges.
    Spika JS; Wassilak S; Pebody R; Lipskaya G; Deshevoi S; Guris D; Emiroglu N
    J Infect Dis; 2003 May; 187 Suppl 1():S191-7. PubMed ID: 12721913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.